Cary Street Partners Investment Advisory’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10
Closed -$659 1692
2023
Q3
$659 Hold
10
﹤0.01% 1777
2023
Q2
$814 Hold
10
﹤0.01% 1667
2023
Q1
$594 Hold
10
﹤0.01% 1600
2022
Q4
$488 Buy
+10
New +$462 ﹤0.01% 1619

Other funds holding THC

Cary Street Partners Investment Advisory's THC Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Tenet Healthcare (THC) in Q4 2023, closing a stake of 10 shares — an estimated $659 sold.

Cary Street Partners Investment Advisory first reported a position in THC in Q4 2022 and held it in 4 quarters. The position peaked at $814 in Q2 2023. 425 funds tracked by Wall St. Rank hold THC as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Tenet Healthcare position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 10 Tenet Healthcare shares in Q4 2023, an estimated $659.
  • Cary Street Partners Investment Advisory first reported a position in Tenet Healthcare in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Tenet Healthcare position peaked at $814 in Q2 2023.
  • 425 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.